Scientists unveil surprising human vs mouse differences in a major cancer immunotherapy target

Much of our knowledge of the protein PD-1, a leading cancer treatment target, comes from studies in mice. In a comprehensive assessment of PD-1, researchers have found that PD-1 in mice is significantly weaker than the human version, providing new information on how cancer treatments are developed.
Read more: Scientists unveil surprising human vs mouse differences in a major cancer immunotherapy target